Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pseudomyxoma peritonei]

I Besznyák1, F Pommersheim, J Tóth

  • 1Országos Onkológiai Intézet, Budapest.

Orvosi Hetilap
|December 15, 1996
PubMed
Summary

Peritoneal pseudomyxoma is a rare, slow-growing malignancy. Surgical treatment is primary, but recurrence is common, making complete cures rare even with early diagnosis and surgery.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bevacizumab treatment before resection of colorectal liver metastases: safety, recovery of liver function, pathologic assessment.

Pathology oncology research : POR·2013
Same author

Pleomorphic corneal sarcoma resembling malignant peripheral nerve sheath tumor in a horse.

Veterinary pathology·2009
Same author

Histiocytic and t-cell rich b-cell lymphoma (TCRBCL) of the stomach.

Pathology oncology research : POR·2008
Same author

Successful medical treatment of acute pancreatitis in a horse.

The Veterinary record·2008
Same author

Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome.

Lupus·2007
Same author

The aging kidney: role of endothelial oxidative stress and inflammation.

Acta physiologica Hungarica·2007

Area of Science:

  • Oncology
  • Surgical Pathology

Background:

  • Peritoneal pseudomyxoma is a rare, low-grade malignancy.
  • This review examines the diagnosis and treatment of this condition.

Observation:

  • Clinical cases from the National Institute of Oncology, Budapest, were analyzed.
  • Diagnostic methods include ultrasonography, CT, and laparoscopy, with surgical confirmation.

Findings:

  • The primary treatment modality is surgical intervention.
  • Chemotherapy offers modest benefits.
  • The disease follows an indolent course with a high propensity for recurrence.

Implications:

  • Despite advances in diagnostic imaging and surgical techniques, achieving a complete cure for peritoneal pseudomyxoma remains challenging.
  • Further research into novel therapeutic strategies is warranted to improve patient outcomes.